Syngen BiotechLtd Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Wei Chen
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 18.8yrs |
| CEO ownership | n/a |
| Management average tenure | no data |
| Board average tenure | 10.9yrs |
Recent management updates
Recent updates
Does Syngen BiotechLtd (GTSM:8279) Have A Healthy Balance Sheet?
Mar 25
Should Syngen Biotech Co., Ltd. (GTSM:8279) Be Part Of Your Dividend Portfolio?
Feb 25Did You Miss Syngen Biotech's (GTSM:8279) Impressive 104% Share Price Gain?
Feb 04Is Syngen Biotech Co., Ltd.'s (GTSM:8279) Latest Stock Performance Being Led By Its Strong Fundamentals?
Jan 14Syngen Biotech (GTSM:8279) Seems To Use Debt Quite Sensibly
Dec 16
Syngen Biotech's (GTSM:8279) Earnings Are Growing But Is There More To The Story?
Nov 25CEO
Wei Chen
18.8yrs
Tenure
Wei Ren Chen has been Chairman of the Board and President of Syngen Biotech Co., Ltd. since March 15, 1999 and July 1, 2005 respectively. Wei Ren Chen is employed by Taiwan Drug Relief Foundation.Wei Ren...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board and President | 25.2yrs | no data | no data | |
| Finance Manager and Director | 10.9yrs | no data | no data | |
| Director | 10.9yrs | no data | no data | |
| Director | 10.9yrs | no data | no data | |
| Supervisor | 10.9yrs | no data | no data | |
| Supervisor | 10.9yrs | no data | no data | |
| Director | 10.9yrs | no data | no data |
10.9yrs
Average Tenure
Experienced Board: 8279's board of directors are seasoned and experienced ( 10.9 years average tenure).